Buprenorphine And Naloxone 67296-2228
Product NDC
67296-2228- Manufacturer
- Redpharm Drug
- Dosage Form
- Film
- Route
- Buccal And Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- August 29, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA212756
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(2)
6 POUCH in 1 CARTON (67296-2228-1) / 1 FILM in 1 POUCH
30 POUCH in 1 CARTON (67296-2228-3) / 1 FILM in 1 POUCH